Shingrix - An Adjuvanted, Recombinant Herpes Zoster Vaccine

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2017年 / 59卷 / 1535期
关键词：
SUBUNIT VACCINE; EFFICACY;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
下载
收藏
页码：195 / 196
页数：2
相关论文
共 50 条
  • [31] Herpes Zoster and Varicella Encephalitis Following the Recombinant Zoster Vaccine
    Pane, Mallory
    Harrell, Catherine
    Pickell, Stuart C.
    CUTIS, 2024, 113 (02): : E14 - E15
  • [32] HERPES ZOSTER IN INDIVIDUALS WITH AUTOIMMUNE DISEASES AND RECOMBINANT HERPES ZOSTER VACCINE AS A PREVENTATIVE STRATEGY
    Winthrop, K.
    Farraye, F. A.
    Sullivan, K. M.
    Willer, D. O.
    Vink, P.
    Tavares-Da-Silva, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1655 - 1656
  • [33] Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine
    Grupping, Katrijn
    Campora, Laura
    Douha, Martine
    Heineman, Thomas C.
    Klein, Nicola P.
    Lal, Himal
    Peterson, James
    Vastiau, Ilse
    Oostvogels, Lidia
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 (11): : 1343 - 1351
  • [34] Use of Recombinant Zoster Vaccine (RZV-Shingrix) in Patients With Inflammatory Bowel Disease
    Reich, Jason
    Li Pei-Hsuan
    Zahorian, Toni
    Noronha, Ansu
    Wasan, Sharmeel K.
    Farraye, Francis A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S400 - S400
  • [35] SAFETY OF RECOMBINANT ZOSTER VACCINE (RZV-SHINGRIX) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Satyam, Venkata R.
    Li, Pei-Hsuan
    Reich, Jason
    Qazi, Taha
    Noronha, Ansu
    Wasan, Sharmeel K.
    Farraye, Francis A.
    GASTROENTEROLOGY, 2019, 156 (06) : S665 - S666
  • [36] Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination
    Bruxvoort, Katia J.
    Qian, Lei
    Wu, Jun
    Florea, Ana
    Ackerson, Bradley
    Sy, Lina S.
    Daily, Leticia Vega
    Takhar, Harpreet
    Tseng, Hung Fu
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (03):
  • [37] Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States
    Lu, Angela
    Sun, Yuwei
    Porco, Travis C.
    Arnold, Benjamin F.
    Acharya, Nisha R.
    OPHTHALMOLOGY, 2021, 128 (12) : 1699 - 1707
  • [38] Herpes zoster after recombinant zoster vaccine: A first case report
    Housel, Laurie A.
    McClenathan, Bruce M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 772 - +
  • [39] In adults ≥ 70 years of age, an adjuvanted herpes zoster subunit vaccine reduced herpes zoster at a mean 3.7 years
    Sacks, Henry S.
    ANNALS OF INTERNAL MEDICINE, 2017, 166 (02) : JC5 - JC5
  • [40] Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention
    Lecrenier, Nicolas
    Beukelaers, Pierre
    Colindres, Romulo
    Curran, Desmond
    De Kesel, Carine
    De Saegher, Jean-Philippe
    Didierlaurent, Arnaud M.
    Ledent, Edouard Y.
    Mols, Johann F.
    Mrkvan, Tomas
    Normand-Bayle, Marie
    Oostvogels, Lidia
    Da Silva, Fernanda Tavares
    Vassilev, Ventzislav
    Vinals, Carlota
    Brecx, Alain
    EXPERT REVIEW OF VACCINES, 2018, 17 (07) : 619 - 634
12345